Intel Capital exited the spatial sound technology developer through an acquisition by Google in December last year.
The Novo-backed musculoskeletal disease therapy developer's market capitalisation stood at $1.6bn as of close of trading yesterday.
GV and Alexa Fund have exited the sports discussion app's owner, Betty Labs, in an acquisition of undisclosed size by Spotify.
The Amazon-backed food delivery service raised $2.07bn in its initial public offering only to see its shares fall some 25% on its opening day.
The online learning platform developer spun out of Stanford University priced its shares at the top of their range.
CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.
Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.
The Seek Group, Laureate Education and BCC-backed online learning platform developer priced its shares at the top of their range.
SoftBank’s SB Management subsidiary, Illumina and Novartis are backing a $375m PIPE supporting the deal, which values the proteomics technology provider at $1.23bn.
Ingka Group-backed vertical farm operator Aerofarms is joining forces with a special purpose acquisition company at a $1.2bn post-transaction valuation.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
